RIG
LLY icon

RiverFront Investment Group’s Eli Lilly LLY Stock Holding History

RiverFront Investment Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5M Buy
32,968
+2,029
+7% +$2.07M 0.52% 48
2026
Q1 		$28.5M Buy
30,939
+1,834
+6% +$1.86M 0.44% 51
2025
Q4 		$31.3M Buy
29,105
+5,475
+23% +$5.24M 0.52% 47
2025
Q3 		$18M Buy
23,630
+6,257
+36% +$4.66M 0.32% 59
2025
Q2 		$13.5M Buy
17,373
+7,982
+85% +$6.2M 0.26% 62
2025
Q1 		$7.76M Buy
9,391
+4,235
+82% +$3.52M 0.17% 68
2024
Q4 		$3.98M Buy
5,156
+2,569
+99% +$2.13M 0.09% 80
2024
Q3 		$2.29M Buy
2,587
+2,304
+814% +$2.07M 0.05% 82
2024
Q2 		$256K Buy
+283
New +$226K 0.01% 148
2021
Q3 		– Sell
-1,397
Closed -$321K – 117
2021
Q2 		$321K Buy
1,397
+239
+21% +$48K 0.01% 80
2021
Q1 		$216K Sell
1,158
-292
-20% -$57.1K ﹤0.01% 119
2020
Q4 		$245K Buy
+1,450
New +$216K 0.01% 77

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RiverFront Investment Group's LLY Position: Q2 2026 in Review

RiverFront Investment Group increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $2.07M and bringing the position to 32,968 shares worth $39.5M. The position accounts for 0.52% of the portfolio, ranked #48.

RiverFront Investment Group first reported a position in LLY in Q4 2020 and has held it in 12 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RiverFront Investment Group held 32,968 shares of Eli Lilly worth $39.5M as of Q2 2026.
  • RiverFront Investment Group bought 2,029 Eli Lilly shares in Q2 2026, an estimated $2.07M.
  • Eli Lilly made up 0.52% of RiverFront Investment Group's portfolio in Q2 2026, its #48 holding.
  • RiverFront Investment Group first reported a position in Eli Lilly in Q4 2020 and has held it in 12 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.